Europe Contraceptives Market

Market Introduction

The European market includes the consolidated markets for France, Germany, United Kingdom, Italy, Spain, and Rest of Europe. The market growth in the region is expected due to growing awareness among the population, increasing prevalence of sexually transmitted infections and government support for family planning. Growing support for family planning and reproductive health is likely to favor the market. Sex education is compulsory in German schools and a 1995 Federal Act ensures the right to information and advice on sex education, prevention, and family planning. The act establishes a Federal Center for Health Education and also funds the establishment of advisory centers. Pills and condoms are common contraceptives in Germany. Women below the age of 20 years are can obtain free contraceptives and medical consultations. Further, women above the age of 20 years can receive free IUDs. The German government committed EUR 514 million to family planning and reproductive health in 2017. This commitment is in line with Maternal Health Initiative, which focuses to provide information and access to modern contraceptives to around nine million couples. Surge in product innovations and launches is the major factor driving the growth of the Europe contraceptives market.

The high impact of the COVID-19 pandemic on reproductive health patients is high in terms of anxiety, fear, and psychological distress. Among all European countries, Spain, Italy, Germany, France, and the UK are most affected due to the increasing number of coronavirus cases and deaths associated with it. As per the Worldometer as of March 22, 2021, in Spain, Italy, Germany, France, UK and Netherlands, Belgium, and Luxembourg, the number of cases is 3,212,332, 3,376,376; 2,670,000; 4,282,603; 4,296,583; 1,201,545; 837,006; 59,416; respective and number of deaths are also high. WHO/Europe has assisted countries in developing an evidence-based approach to family planning and the introduction and adaption of WHO guidelines. This was done in collaboration with the United Nations Population Fund (UNFPA), the International Planned Parenthood Federation (IPPF), the European Network, the European Society of Contraception and Reproductive Health (ESC), the United States Agency for International Development (USAID) and other organizations. Lockdown took measures in Europe to respond to COVID-19 and imposed major disruptions to contraceptive supply chains. Moreover, according to BBC report of October, 2020, the sale of Durex jumped when social-distancing rules were relaxed in the summer, and also stated that, 2020 has been an extraordinary time for condom manufacturer and contraceptives business. The companies have seen, customers taking time to truly invest in their mental and sexual wellbeing. Therefore, in the long run the market has strong potential to boost the growth rate as Europe is the most populated region in the world and where a large number of condoms is being used in lockdown.

Market Overview and Dynamics

The contraceptives market in Europe is expected to grow from US$ 5,573.28 million in 2021 to US$ 7,321.42 million by 2028; it is estimated to grow at a CAGR of 4.0% from 2021 to 2028. Traditional contraceptives such as IUDs are invasive, and birth control pills may cause side effects such as high menstrual bleeding, acne, and hormonal imbalance. The demand for alternative options has led to the emergence of digital technological contraceptive solutions that allow women to plan family without harmful side effects. Many web-based applications are being launched frequently, which provide hormone-free family planning options. Contraception-focused smartphone apps use algorithms to track entered fertility signs over time, then alert users to avoid intercourse on their peak fertility days. In 2018, the Natural Cycles app received the FDA approval and became the first direct-to-consumer digital birth control app, to lead the way of non-hormonal and non-invasive birth control options. Natural Cycles’ approval is based on the study of more than 15,000 women and 180,000 cycles, and it claims a 93% success rate, the same as a contraceptive pill. On March 1, 2021, another digital birth control app—Clue—received an FDA clearance and to become the second contraceptive app. Pexxi, founded in 2018, offers a personalized oral contraception service by combining data from an online questionnaire and hormone test kits to predict the best pill for individual women. The company also offers monitoring services to help women to track the effects of the pill over time. In case of any side effects on health due to birth control pills, it can offer alternative suggestions. This is how digital fertility methods can be used for family planning.

Key Market Segments

The market for Europe contraceptives market is segmented into product, end user, and distribution channel, and country. Based on product, the market is segmented condoms, intrauterine product (IUDs), vaginal rings, implants, patches, diaphragms, emergency contraceptives, sponges, and others. The condoms segment dominated the market in 2020 and intrauterine product (IUDs) segment is expected to be the fastest growing during the forecast period. Further, the segment   condoms has been bifurcated into female condoms and male condoms. Similarly, the intrauterine product (IUDs) is bifurcated into hormonal IUDs and copper IUDs. Based on end user, the market is segmented into home care, and hospitals and clinics. The home care segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on distribution channel, the market is segmented into retail pharmacy, online pharmacy, and hospital pharmacy. The retail pharmacy segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the contraceptives market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Bayer AG; Church & Dwight, Inc.; CooperSurgical (Cooper Companies, Inc.); HLL Lifecare Limited; and Merck & Co., Inc. among others.

Reasons to buy report

• To understand the Europe contraceptives market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe contraceptives market
• Efficiently plan M&A and partnership deals in Europe contraceptives market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe contraceptives market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

Europe Contraceptives Market Segmentation
Europe Contraceptives Market -By Product

• Condoms
  • Male Condoms
  • Female Condoms
• Intrauterine Product (IUDs)
  • Hormonal IUDs
  • Copper IUDs
• Vaginal Rings
• Implants
• Patches
• Diaphragms
• Emergency Contraceptives
• Sponges
• Others

Europe Contraceptives Market -By End User

• Home Care
• Hospitals and Clinics

Europe Contraceptives Market -By Distribution Channel

• Retail Pharmacy
• Online Pharmacy
• Hospital Pharmacy

Europe Contraceptives Market -By Country

• Germany
• UK
• France
• Italy
• Spain
• Ukraine
• Estonia
• Bulgaria
• Lithuania
• Romania
• Georgia
• Rest of Europe

Europe Contraceptives Market -Company Profiles

• Bayer AG
• Church & Dwight, Inc.
• CooperSurgical (Cooper Companies, Inc.)
• HLL Lifecare Limited
• Merck & Co., Inc.

Europe Contraceptives Market Strategic Insights

Europe Contraceptives Market Segmentation Analysis

Europe Contraceptives Market Report Highlights

Europe Contraceptives Report Scope

Europe Contraceptives Market Country and Regional Insights